A pharmaceutical business from Loughborough has won a national competition to find Britain’s top start-ups. OncoTherics, which is developing drug technology to target aggressive cancer tumours, has won the opportunity to exhibit at the Conservative Party Conference in Manchester.
OncoTherics is one of a dozen start-up businesses selected from thousands of entrants from across all sectors of industry. It is the only company on the shortlist that represents drug research and development in Britain. OncoTherics have showcased their work at the Start-up Hub in front of thousands of delegates, the nation’s media and business leaders from across the country, as they unveiled details of their highly-targeted cancer inhibiting technology that has sparked the interest of leading cancer charities such as Prostate Cancer UK and leading pharmaceutical companies such as Astra Zeneca. It’s hoped OncoTherics drug technology could represent the biggest step forward in the treatment of Pancreatic cancer for more than two decades.
The national competition, launched two years ago, presented a chance for 12 new businesses to demonstrate their ideas or designs during the four day conference running from Sunday, September 29th to Wednesday, October 2nd.
OncoTherics also scooped the overall winner from the twelve finalists. The business won the top prize after conference delegates voted for their favourite.
Nicky Morgan, MP for Loughborough, said:
“I am thrilled that OncoTherics was chosen to exhibit at Conference. This is a unique opportunity for the winning entrepreneurs and a fantastic chance to show off their work to thousands of delegates, the nation’s media and business leaders from across the country. I was also delighted to hear that the business had one top prize as well!”
Stefan Ogrodzinski from OncoTherics said:
“OncoTherics has developed an exciting and novel drug technology for treating severe cancers. Exhibiting at the Start-Up Hub is a fantastic opportunity to raise awareness of the company, our exciting new drug technology and the investment opportunity.”